Product Program year 2025 Source: CMS Open Payments

Clinical Trial Product

Device Clinical Trial Product_URO

Open in the dashboard

General payments

$112,936

21 payments

Research payments

$360,963

114 payments

Through program year 2025, $112,936 in general payments and $360,963 in research payments were reported against Clinical Trial Product (Clinical Trial Product_URO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $112,841 16
2025 Research $62,804 28
2024 Research $298,160 86
2022 General $94 5

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $112,936 21 payments
Top recipients General payments · program year 2025
  1. Michael McDonald Urology · Celebration, FL $64,250 57% · 1 payment
  2. Sean Collins Radiation Oncology · Washington, DC $27,300 24% · 7 payments
  3. David Lichtenstein Gastroenterology · Philadelphia, PA $12,250 11% · 4 payments
  4. Kelvin Moses Urology · Nashville, TN $9,000 8% · 2 payments
  5. David Anderson Urology · Springfield, MO $24 <1% · 1 payment

The top 5 of 6 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $73,274 65% · 3 practitioners
  2. Radiation Oncology Radiology $27,300 24% · 1 practitioner
  3. Gastroenterology Internal Medicine $12,250 11% · 1 practitioner
  4. Nurse Anesthetist, Certified Registered $17 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Florida $64,325 57% · 2 recipients
  2. District of Columbia $27,225 24% · 1 recipient
  3. Pennsylvania $12,250 11% · 1 recipient
  4. Tennessee $9,000 8% · 1 recipient
  5. Missouri $24 <1% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

21 general · 114 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record